{"transactions":[{"id":748179,"issuer":{"id":1008,"kind":"organization","name":"RECURSION PHARMACEUTICALS, INC.","symbol":"RXRX"},"owners":[{"id":40978,"kind":"person","name":"Gibson Christopher","position":1,"cik":"0001856369","reported_name":"Gibson Christopher","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class B Common Stock","published_at":"2026-06-05T21:03:03.000Z","date":"2026-06-05","kind":"exercise","planned":true,"acquired":false,"shares":40000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Each share of Class B Common Stock is convertible into one share of Class A Common Stock at the option of the holder and has no expiration date."},{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents the automatic conversion of Class B Common Stock into Class A Common Stock in connection with a sale of the shares by the Reporting Person.  Each share of Class B Common Stock is convertible into one share of Class A Common Stock."},{"field":"kind","element":"transactionCoding","label":"F2","text":"This transaction is pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 12, 2025."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Each share of Class B Common Stock is convertible into one share of Class A Common Stock at the option of the holder and has no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Each share of Class B Common Stock is convertible into one share of Class A Common Stock at the option of the holder and has no expiration date."}],"balance_after":4263334,"derivative":{"exercise_price":0,"underlying":"Class A Common Stock","underlying_shares":40000},"source":{"system":"sec-edgar","filing":"0001856369-26-000023","document":"wk-form4_1780693380.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1856369/000185636926000023/wk-form4_1780693380.xml","form_type":"4"}},{"id":748178,"issuer":{"id":1008,"kind":"organization","name":"RECURSION PHARMACEUTICALS, INC.","symbol":"RXRX"},"owners":[{"id":40978,"kind":"person","name":"Gibson Christopher","position":1,"cik":"0001856369","reported_name":"Gibson Christopher","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2026-06-05T21:03:03.000Z","date":"2026-06-05","kind":"sale","planned":true,"acquired":false,"shares":40000,"price":3.62,"value":144800.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"This transaction is pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 12, 2025."}],"balance_after":883735,"source":{"system":"sec-edgar","filing":"0001856369-26-000023","document":"wk-form4_1780693380.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1856369/000185636926000023/wk-form4_1780693380.xml","form_type":"4"}},{"id":748177,"issuer":{"id":1008,"kind":"organization","name":"RECURSION PHARMACEUTICALS, INC.","symbol":"RXRX"},"owners":[{"id":40978,"kind":"person","name":"Gibson Christopher","position":1,"cik":"0001856369","reported_name":"Gibson Christopher","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2026-06-05T21:03:03.000Z","date":"2026-06-05","kind":"exercise","planned":true,"acquired":true,"shares":40000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents the automatic conversion of Class B Common Stock into Class A Common Stock in connection with a sale of the shares by the Reporting Person.  Each share of Class B Common Stock is convertible into one share of Class A Common Stock."},{"field":"kind","element":"transactionCoding","label":"F2","text":"This transaction is pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 12, 2025."}],"balance_after":923735,"source":{"system":"sec-edgar","filing":"0001856369-26-000023","document":"wk-form4_1780693380.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1856369/000185636926000023/wk-form4_1780693380.xml","form_type":"4"}},{"id":749740,"issuer":{"id":5650,"kind":"organization","name":"PACIFIC BIOSCIENCES OF CALIFORNIA, INC.","symbol":"PACB"},"owners":[{"id":40978,"kind":"person","name":"Gibson Christopher","position":1,"cik":"0001856369","reported_name":"Gibson Christopher","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2026-06-04T21:26:18.000Z","date":"2026-06-03","kind":"grant","planned":false,"acquired":true,"shares":74497,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the option will vest monthly over one (1) year, on the same day of the month as the date of grant or, if earlier, on the date of the next annual meeting of the Company's stockholders occurring after the date of grant, provided such Reporting Person continues to serve as a director through the applicable vesting dates."}],"balance_after":74497,"derivative":{"exercise_price":1.58,"exercise_date":"2026-07-03","expiration_date":"2036-06-03","underlying":"Common Stock","underlying_shares":74497},"source":{"system":"sec-edgar","filing":"0001299130-26-000106","document":"wk-form4_1780608376.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1856369/000129913026000106/wk-form4_1780608376.xml","form_type":"4"}},{"id":762018,"issuer":{"id":1008,"kind":"organization","name":"RECURSION PHARMACEUTICALS, INC.","symbol":"RXRX"},"owners":[{"id":40978,"kind":"person","name":"Gibson Christopher","position":1,"cik":"0001856369","reported_name":"Gibson Christopher","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class B Common Stock","published_at":"2026-05-27T20:15:15.000Z","date":"2026-05-22","kind":"exercise","planned":true,"acquired":false,"shares":40000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Each share of Class B Common Stock is convertible into one share of Class A Common Stock at the option of the holder and has no expiration date."},{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction is pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 12, 2025."},{"field":"kind","element":"transactionCoding","label":"F2","text":"Represents the automatic conversion of Class B Common Stock into Class A Common Stock in connection with a sale of the shares by the Reporting Person.  Each share of Class B Common Stock is convertible into one share of Class A Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Each share of Class B Common Stock is convertible into one share of Class A Common Stock at the option of the holder and has no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Each share of Class B Common Stock is convertible into one share of Class A Common Stock at the option of the holder and has no expiration date."}],"balance_after":4303334,"derivative":{"exercise_price":0,"underlying":"Class A Common Stock","underlying_shares":40000},"source":{"system":"sec-edgar","filing":"0001856369-26-000019","document":"wk-form4_1779912912.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1856369/000185636926000019/wk-form4_1779912912.xml","form_type":"4"}},{"id":762017,"issuer":{"id":1008,"kind":"organization","name":"RECURSION PHARMACEUTICALS, INC.","symbol":"RXRX"},"owners":[{"id":40978,"kind":"person","name":"Gibson Christopher","position":1,"cik":"0001856369","reported_name":"Gibson Christopher","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2026-05-27T20:15:15.000Z","date":"2026-05-22","kind":"sale","planned":true,"acquired":false,"shares":40000,"price":3.08,"value":123200.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction is pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 12, 2025."}],"balance_after":883735,"source":{"system":"sec-edgar","filing":"0001856369-26-000019","document":"wk-form4_1779912912.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1856369/000185636926000019/wk-form4_1779912912.xml","form_type":"4"}},{"id":762016,"issuer":{"id":1008,"kind":"organization","name":"RECURSION PHARMACEUTICALS, INC.","symbol":"RXRX"},"owners":[{"id":40978,"kind":"person","name":"Gibson Christopher","position":1,"cik":"0001856369","reported_name":"Gibson Christopher","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2026-05-27T20:15:15.000Z","date":"2026-05-22","kind":"exercise","planned":true,"acquired":true,"shares":40000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction is pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 12, 2025."},{"field":"kind","element":"transactionCoding","label":"F2","text":"Represents the automatic conversion of Class B Common Stock into Class A Common Stock in connection with a sale of the shares by the Reporting Person.  Each share of Class B Common Stock is convertible into one share of Class A Common Stock."}],"balance_after":923735,"source":{"system":"sec-edgar","filing":"0001856369-26-000019","document":"wk-form4_1779912912.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1856369/000185636926000019/wk-form4_1779912912.xml","form_type":"4"}},{"id":772325,"issuer":{"id":1008,"kind":"organization","name":"RECURSION PHARMACEUTICALS, INC.","symbol":"RXRX"},"owners":[{"id":40978,"kind":"person","name":"Gibson Christopher","position":1,"cik":"0001856369","reported_name":"Gibson Christopher","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2026-05-19T21:54:36.000Z","date":"2026-05-15","kind":"tax_withholding","planned":false,"acquired":false,"shares":22821,"price":3.04,"value":69375.84,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares that have been withheld by the Issuer to satisfy its tax withholding and remittance obligations in connection with the net settlement of restricted stock units."}],"balance_after":883735,"source":{"system":"sec-edgar","filing":"0001856369-26-000017","document":"wk-form4_1779227673.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1856369/000185636926000017/wk-form4_1779227673.xml","form_type":"4"}},{"id":786978,"issuer":{"id":1008,"kind":"organization","name":"RECURSION PHARMACEUTICALS, INC.","symbol":"RXRX"},"owners":[{"id":40978,"kind":"person","name":"Gibson Christopher","position":1,"cik":"0001856369","reported_name":"Gibson Christopher","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class B Common Stock","published_at":"2026-05-08T20:59:21.000Z","date":"2026-05-07","kind":"exercise","planned":true,"acquired":false,"shares":60000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each share of Class B Common Stock is convertible into one share of Class A Common Stock at the option of the holder and has no expiration date."},{"field":"kind","element":"transactionCoding","label":"F1","text":"Each share of Class B Common Stock is convertible into one share of Class A Common Stock at the option of the holder and has no expiration date."},{"field":"kind","element":"transactionCoding","label":"F2","text":"This transaction is pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 12, 2025."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each share of Class B Common Stock is convertible into one share of Class A Common Stock at the option of the holder and has no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each share of Class B Common Stock is convertible into one share of Class A Common Stock at the option of the holder and has no expiration date."}],"balance_after":4343334,"derivative":{"exercise_price":0,"underlying":"Class A Common Stock","underlying_shares":60000},"source":{"system":"sec-edgar","filing":"0001856369-26-000015","document":"wk-form4_1778273958.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1856369/000185636926000015/wk-form4_1778273958.xml","form_type":"4"}},{"id":786977,"issuer":{"id":1008,"kind":"organization","name":"RECURSION PHARMACEUTICALS, INC.","symbol":"RXRX"},"owners":[{"id":40978,"kind":"person","name":"Gibson Christopher","position":1,"cik":"0001856369","reported_name":"Gibson Christopher","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2026-05-08T20:59:21.000Z","date":"2026-05-07","kind":"gift","planned":true,"acquired":false,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"This transaction is pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 12, 2025."}],"balance_after":906556,"source":{"system":"sec-edgar","filing":"0001856369-26-000015","document":"wk-form4_1778273958.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1856369/000185636926000015/wk-form4_1778273958.xml","form_type":"4"}},{"id":786976,"issuer":{"id":1008,"kind":"organization","name":"RECURSION PHARMACEUTICALS, INC.","symbol":"RXRX"},"owners":[{"id":40978,"kind":"person","name":"Gibson Christopher","position":1,"cik":"0001856369","reported_name":"Gibson Christopher","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2026-05-08T20:59:21.000Z","date":"2026-05-07","kind":"sale","planned":true,"acquired":false,"shares":40000,"price":3.37,"value":134800.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"This transaction is pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 12, 2025."}],"balance_after":926556,"source":{"system":"sec-edgar","filing":"0001856369-26-000015","document":"wk-form4_1778273958.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1856369/000185636926000015/wk-form4_1778273958.xml","form_type":"4"}},{"id":786975,"issuer":{"id":1008,"kind":"organization","name":"RECURSION PHARMACEUTICALS, INC.","symbol":"RXRX"},"owners":[{"id":40978,"kind":"person","name":"Gibson Christopher","position":1,"cik":"0001856369","reported_name":"Gibson Christopher","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2026-05-08T20:59:21.000Z","date":"2026-05-07","kind":"exercise","planned":true,"acquired":true,"shares":60000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Each share of Class B Common Stock is convertible into one share of Class A Common Stock at the option of the holder and has no expiration date."},{"field":"kind","element":"transactionCoding","label":"F2","text":"This transaction is pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 12, 2025."}],"balance_after":966556,"source":{"system":"sec-edgar","filing":"0001856369-26-000015","document":"wk-form4_1778273958.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1856369/000185636926000015/wk-form4_1778273958.xml","form_type":"4"}},{"id":801037,"issuer":{"id":1008,"kind":"organization","name":"RECURSION PHARMACEUTICALS, INC.","symbol":"RXRX"},"owners":[{"id":40978,"kind":"person","name":"Gibson Christopher","position":1,"cik":"0001856369","reported_name":"Gibson Christopher","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class B Common Stock","published_at":"2026-04-24T20:23:14.000Z","date":"2026-04-22","kind":"exercise","planned":true,"acquired":false,"shares":40000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each share of Class B Common Stock is convertible into one share of Class A Common Stock at the option of the holder and has no expiration date."},{"field":"kind","element":"transactionCoding","label":"F1","text":"Each share of Class B Common Stock is convertible into one share of Class A Common Stock at the option of the holder and has no expiration date."},{"field":"kind","element":"transactionCoding","label":"F2","text":"This transaction is pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 12, 2025."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each share of Class B Common Stock is convertible into one share of Class A Common Stock at the option of the holder and has no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each share of Class B Common Stock is convertible into one share of Class A Common Stock at the option of the holder and has no expiration date."}],"balance_after":4403334,"derivative":{"exercise_price":0,"underlying":"Class A Common Stock","underlying_shares":40000},"source":{"system":"sec-edgar","filing":"0001856369-26-000013","document":"wk-form4_1777062192.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1856369/000185636926000013/wk-form4_1777062192.xml","form_type":"4"}},{"id":801036,"issuer":{"id":1008,"kind":"organization","name":"RECURSION PHARMACEUTICALS, INC.","symbol":"RXRX"},"owners":[{"id":40978,"kind":"person","name":"Gibson Christopher","position":1,"cik":"0001856369","reported_name":"Gibson Christopher","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2026-04-24T20:23:14.000Z","date":"2026-04-22","kind":"sale","planned":true,"acquired":false,"shares":40000,"price":3.61,"value":144400.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"This transaction is pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 12, 2025."}],"balance_after":906556,"source":{"system":"sec-edgar","filing":"0001856369-26-000013","document":"wk-form4_1777062192.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1856369/000185636926000013/wk-form4_1777062192.xml","form_type":"4"}},{"id":801035,"issuer":{"id":1008,"kind":"organization","name":"RECURSION PHARMACEUTICALS, INC.","symbol":"RXRX"},"owners":[{"id":40978,"kind":"person","name":"Gibson Christopher","position":1,"cik":"0001856369","reported_name":"Gibson Christopher","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2026-04-24T20:23:14.000Z","date":"2026-04-22","kind":"exercise","planned":true,"acquired":true,"shares":40000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Each share of Class B Common Stock is convertible into one share of Class A Common Stock at the option of the holder and has no expiration date."},{"field":"kind","element":"transactionCoding","label":"F2","text":"This transaction is pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 12, 2025."}],"balance_after":946556,"source":{"system":"sec-edgar","filing":"0001856369-26-000013","document":"wk-form4_1777062192.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1856369/000185636926000013/wk-form4_1777062192.xml","form_type":"4"}},{"id":810523,"issuer":{"id":5650,"kind":"organization","name":"PACIFIC BIOSCIENCES OF CALIFORNIA, INC.","symbol":"PACB"},"owners":[{"id":40978,"kind":"person","name":"Gibson Christopher","position":1,"cik":"0001856369","reported_name":"Gibson Christopher","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2026-04-10T20:05:39.000Z","date":"2026-04-08","kind":"grant","planned":false,"acquired":true,"shares":77842,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"One-third of the shares subject to the option will vest on March 3, 2027, which is the one year anniversary of Mr. Gibson joining the Board, and the remainder will vest in equal monthly installments\nthereafter for 24 months on the same date of the month as his initial start date, provided he continues to serve as a director through each vesting date."}],"balance_after":77842,"derivative":{"exercise_price":1.52,"exercise_date":"2027-03-03","expiration_date":"2036-04-08","underlying":"Common Stock","underlying_shares":77842},"source":{"system":"sec-edgar","filing":"0001856369-26-000010","document":"wk-form4_1775851536.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1856369/000185636926000010/wk-form4_1775851536.xml","form_type":"4"}},{"id":810522,"issuer":{"id":5650,"kind":"organization","name":"PACIFIC BIOSCIENCES OF CALIFORNIA, INC.","symbol":"PACB"},"owners":[{"id":40978,"kind":"person","name":"Gibson Christopher","position":1,"cik":"0001856369","reported_name":"Gibson Christopher","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-04-10T20:05:39.000Z","date":"2026-04-08","kind":"grant","planned":false,"acquired":true,"shares":57473,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Mr. Gibson was elected to the Board of Directors on March 3, 2026. Each share is represented by a Restricted Stock Unit (\"RSU\"). The RSUs will vest in equal annual installments on March 3rd of\neach of 2027, 2028, and 2029, provided such Reporting Person continues to serve as a director through the applicable vesting dates."}],"balance_after":111386,"source":{"system":"sec-edgar","filing":"0001856369-26-000010","document":"wk-form4_1775851536.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1856369/000185636926000010/wk-form4_1775851536.xml","form_type":"4"}},{"id":812635,"issuer":{"id":1008,"kind":"organization","name":"RECURSION PHARMACEUTICALS, INC.","symbol":"RXRX"},"owners":[{"id":40978,"kind":"person","name":"Gibson Christopher","position":1,"cik":"0001856369","reported_name":"Gibson Christopher","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class B Common Stock","published_at":"2026-04-08T20:58:25.000Z","date":"2026-04-07","kind":"exercise","planned":true,"acquired":false,"shares":40000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each share of Class B Common Stock is convertible into one share of Class A Common Stock at the option of the holder and has no expiration date."},{"field":"kind","element":"transactionCoding","label":"F1","text":"Each share of Class B Common Stock is convertible into one share of Class A Common Stock at the option of the holder and has no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each share of Class B Common Stock is convertible into one share of Class A Common Stock at the option of the holder and has no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each share of Class B Common Stock is convertible into one share of Class A Common Stock at the option of the holder and has no expiration date."}],"balance_after":4443334,"derivative":{"exercise_price":0,"underlying":"Class A Common Stock","underlying_shares":40000},"source":{"system":"sec-edgar","filing":"0001856369-26-000008","document":"wk-form4_1775681902.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1856369/000185636926000008/wk-form4_1775681902.xml","form_type":"4"}},{"id":812634,"issuer":{"id":1008,"kind":"organization","name":"RECURSION PHARMACEUTICALS, INC.","symbol":"RXRX"},"owners":[{"id":40978,"kind":"person","name":"Gibson Christopher","position":1,"cik":"0001856369","reported_name":"Gibson Christopher","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2026-04-08T20:58:25.000Z","date":"2026-04-07","kind":"sale","planned":true,"acquired":false,"shares":40000,"price":3.1,"value":124000.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"This transaction is pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 12, 2025."}],"balance_after":906556,"source":{"system":"sec-edgar","filing":"0001856369-26-000008","document":"wk-form4_1775681902.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1856369/000185636926000008/wk-form4_1775681902.xml","form_type":"4"}},{"id":812633,"issuer":{"id":1008,"kind":"organization","name":"RECURSION PHARMACEUTICALS, INC.","symbol":"RXRX"},"owners":[{"id":40978,"kind":"person","name":"Gibson Christopher","position":1,"cik":"0001856369","reported_name":"Gibson Christopher","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2026-04-08T20:58:25.000Z","date":"2026-04-07","kind":"exercise","planned":true,"acquired":true,"shares":40000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Each share of Class B Common Stock is convertible into one share of Class A Common Stock at the option of the holder and has no expiration date."},{"field":"kind","element":"transactionCoding","label":"F2","text":"This transaction is pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 12, 2025."}],"balance_after":946556,"source":{"system":"sec-edgar","filing":"0001856369-26-000008","document":"wk-form4_1775681902.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1856369/000185636926000008/wk-form4_1775681902.xml","form_type":"4"}},{"id":828297,"issuer":{"id":1008,"kind":"organization","name":"RECURSION PHARMACEUTICALS, INC.","symbol":"RXRX"},"owners":[{"id":40978,"kind":"person","name":"Gibson Christopher","position":1,"cik":"0001856369","reported_name":"Gibson Christopher","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class B Common Stock","published_at":"2026-03-25T20:36:02.000Z","date":"2026-03-23","kind":"exercise","planned":true,"acquired":false,"shares":40000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each share of Class B Common Stock is convertible into one share of Class A Common Stock at the option of the holder and has no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each share of Class B Common Stock is convertible into one share of Class A Common Stock at the option of the holder and has no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each share of Class B Common Stock is convertible into one share of Class A Common Stock at the option of the holder and has no expiration date."}],"balance_after":4483334,"derivative":{"exercise_price":0,"underlying":"Class A Common Stock","underlying_shares":40000},"source":{"system":"sec-edgar","filing":"0001601830-26-000052","document":"wk-form4_1774470960.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1856369/000160183026000052/wk-form4_1774470960.xml","form_type":"4"}},{"id":828296,"issuer":{"id":1008,"kind":"organization","name":"RECURSION PHARMACEUTICALS, INC.","symbol":"RXRX"},"owners":[{"id":40978,"kind":"person","name":"Gibson Christopher","position":1,"cik":"0001856369","reported_name":"Gibson Christopher","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2026-03-25T20:36:02.000Z","date":"2026-03-23","kind":"sale","planned":true,"acquired":false,"shares":40000,"price":3.25,"value":130000.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"This transaction is pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 12, 2025."}],"balance_after":906556,"source":{"system":"sec-edgar","filing":"0001601830-26-000052","document":"wk-form4_1774470960.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1856369/000160183026000052/wk-form4_1774470960.xml","form_type":"4"}},{"id":828295,"issuer":{"id":1008,"kind":"organization","name":"RECURSION PHARMACEUTICALS, INC.","symbol":"RXRX"},"owners":[{"id":40978,"kind":"person","name":"Gibson Christopher","position":1,"cik":"0001856369","reported_name":"Gibson Christopher","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2026-03-25T20:36:02.000Z","date":"2026-03-23","kind":"exercise","planned":true,"acquired":true,"shares":40000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Each share of Class B Common Stock is convertible into one share of Class A Common Stock at the option of the holder and has no expiration date."},{"field":"kind","element":"transactionCoding","label":"F2","text":"This transaction is pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 12, 2025."}],"balance_after":946556,"source":{"system":"sec-edgar","filing":"0001601830-26-000052","document":"wk-form4_1774470960.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1856369/000160183026000052/wk-form4_1774470960.xml","form_type":"4"}},{"id":848892,"issuer":{"id":1008,"kind":"organization","name":"RECURSION PHARMACEUTICALS, INC.","symbol":"RXRX"},"owners":[{"id":40978,"kind":"person","name":"Gibson Christopher","position":1,"cik":"0001856369","reported_name":"Gibson Christopher","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class B Common Stock","published_at":"2026-03-11T21:41:23.000Z","date":"2026-03-09","kind":"exercise","planned":true,"acquired":false,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each share of Class B Common Stock is convertible into one share of Class A Common Stock at the option of the holder and has no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each share of Class B Common Stock is convertible into one share of Class A Common Stock at the option of the holder and has no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each share of Class B Common Stock is convertible into one share of Class A Common Stock at the option of the holder and has no expiration date."}],"balance_after":4523334,"derivative":{"exercise_price":0,"underlying":"Class A Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001601830-26-000049","document":"wk-form4_1773265281.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1856369/000160183026000049/wk-form4_1773265281.xml","form_type":"4"}},{"id":848891,"issuer":{"id":1008,"kind":"organization","name":"RECURSION PHARMACEUTICALS, INC.","symbol":"RXRX"},"owners":[{"id":40978,"kind":"person","name":"Gibson Christopher","position":1,"cik":"0001856369","reported_name":"Gibson Christopher","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2026-03-11T21:41:23.000Z","date":"2026-03-09","kind":"gift","planned":true,"acquired":false,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"This transaction is pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 12, 2025."}],"balance_after":906556,"source":{"system":"sec-edgar","filing":"0001601830-26-000049","document":"wk-form4_1773265281.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1856369/000160183026000049/wk-form4_1773265281.xml","form_type":"4"}},{"id":848890,"issuer":{"id":1008,"kind":"organization","name":"RECURSION PHARMACEUTICALS, INC.","symbol":"RXRX"},"owners":[{"id":40978,"kind":"person","name":"Gibson Christopher","position":1,"cik":"0001856369","reported_name":"Gibson Christopher","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2026-03-11T21:41:23.000Z","date":"2026-03-09","kind":"exercise","planned":true,"acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Each share of Class B Common Stock is convertible into one share of Class A Common Stock at the option of the holder and has no expiration date."},{"field":"kind","element":"transactionCoding","label":"F2","text":"This transaction is pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 12, 2025."}],"balance_after":926556,"source":{"system":"sec-edgar","filing":"0001601830-26-000049","document":"wk-form4_1773265281.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1856369/000160183026000049/wk-form4_1773265281.xml","form_type":"4"}},{"id":858789,"issuer":{"id":5650,"kind":"organization","name":"PACIFIC BIOSCIENCES OF CALIFORNIA, INC.","symbol":"PACB"},"owners":[{"id":40978,"kind":"person","name":"Gibson Christopher","position":1,"cik":"0001856369","reported_name":"Gibson Christopher","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2026-03-05T13:43:24.000Z","date":"2026-03-03","kind":"grant","planned":false,"acquired":true,"shares":73087,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"One-third of the shares subject to the option will vest on March 3, 2027, which is the one year anniversary of Mr. Gibson joining the Board, and the remainder will vest in equal monthly installments thereafter for 24 months on the same date of the month as his initial start date, provided he continues to serve as a director through each vesting date."}],"balance_after":73087,"derivative":{"exercise_price":1.52,"exercise_date":"2027-03-03","expiration_date":"2036-03-03","underlying":"Common Stock","underlying_shares":73087},"source":{"system":"sec-edgar","filing":"0001299130-26-000050","document":"wk-form4_1772718201.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1856369/000129913026000050/wk-form4_1772718201.xml","form_type":"4"}},{"id":858788,"issuer":{"id":5650,"kind":"organization","name":"PACIFIC BIOSCIENCES OF CALIFORNIA, INC.","symbol":"PACB"},"owners":[{"id":40978,"kind":"person","name":"Gibson Christopher","position":1,"cik":"0001856369","reported_name":"Gibson Christopher","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-03-05T13:43:24.000Z","date":"2026-03-03","kind":"grant","planned":false,"acquired":true,"shares":53913,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Mr. Gibson was elected to the Board of Directors on March 3, 2026. Each share is represented by a Restricted Stock Unit (\"RSU\"). The RSUs will vest in equal annual installments on March 3rd of each of 2027, 2028, and 2029, provided such Reporting Person continues to serve as a director through the applicable vesting dates."}],"balance_after":53913,"source":{"system":"sec-edgar","filing":"0001299130-26-000050","document":"wk-form4_1772718201.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1856369/000129913026000050/wk-form4_1772718201.xml","form_type":"4"}},{"id":893584,"issuer":{"id":1008,"kind":"organization","name":"RECURSION PHARMACEUTICALS, INC.","symbol":"RXRX"},"owners":[{"id":40978,"kind":"person","name":"Gibson Christopher","position":1,"cik":"0001856369","reported_name":"Gibson Christopher","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class B Common Stock","published_at":"2026-02-20T00:30:51.000Z","date":"2026-02-19","kind":"exercise","planned":true,"acquired":false,"shares":40000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each share of Class B Common Stock is convertible into one share of Class A Common Stock at the option of the holder and has no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Each share of Class B Common Stock is convertible into one share of Class A Common Stock at the option of the holder and has no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Each share of Class B Common Stock is convertible into one share of Class A Common Stock at the option of the holder and has no expiration date."}],"balance_after":4543334,"derivative":{"exercise_price":0,"underlying":"Class A Common Stock","underlying_shares":40000},"source":{"system":"sec-edgar","filing":"0001601830-26-000021","document":"wk-form4_1771547448.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1856369/000160183026000021/wk-form4_1771547448.xml","form_type":"4"}},{"id":893583,"issuer":{"id":1008,"kind":"organization","name":"RECURSION PHARMACEUTICALS, INC.","symbol":"RXRX"},"owners":[{"id":40978,"kind":"person","name":"Gibson Christopher","position":1,"cik":"0001856369","reported_name":"Gibson Christopher","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2026-02-20T00:30:51.000Z","date":"2026-02-19","kind":"sale","planned":true,"acquired":false,"shares":40000,"price":3.46,"value":138400.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"This transaction is pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 12, 2025."}],"balance_after":906556,"source":{"system":"sec-edgar","filing":"0001601830-26-000021","document":"wk-form4_1771547448.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1856369/000160183026000021/wk-form4_1771547448.xml","form_type":"4"}},{"id":893582,"issuer":{"id":1008,"kind":"organization","name":"RECURSION PHARMACEUTICALS, INC.","symbol":"RXRX"},"owners":[{"id":40978,"kind":"person","name":"Gibson Christopher","position":1,"cik":"0001856369","reported_name":"Gibson Christopher","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2026-02-20T00:30:51.000Z","date":"2026-02-19","kind":"exercise","planned":true,"acquired":true,"shares":40000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Each share of Class B Common Stock is convertible into one share of Class A Common Stock at the option of the holder and has no expiration date."},{"field":"kind","element":"transactionCoding","label":"F3","text":"This transaction is pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 12, 2025."}],"balance_after":946556,"source":{"system":"sec-edgar","filing":"0001601830-26-000021","document":"wk-form4_1771547448.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1856369/000160183026000021/wk-form4_1771547448.xml","form_type":"4"}},{"id":893581,"issuer":{"id":1008,"kind":"organization","name":"RECURSION PHARMACEUTICALS, INC.","symbol":"RXRX"},"owners":[{"id":40978,"kind":"person","name":"Gibson Christopher","position":1,"cik":"0001856369","reported_name":"Gibson Christopher","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2026-02-20T00:30:51.000Z","date":"2026-02-17","kind":"tax_withholding","planned":true,"acquired":false,"shares":27265,"price":3.49,"value":95154.85,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares that have been withheld by the Issuer to satisfy its tax withholding and remittance obligations in connection with the net settlement of restricted stock units."}],"balance_after":906556,"source":{"system":"sec-edgar","filing":"0001601830-26-000021","document":"wk-form4_1771547448.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1856369/000160183026000021/wk-form4_1771547448.xml","form_type":"4"}},{"id":916116,"issuer":{"id":1008,"kind":"organization","name":"RECURSION PHARMACEUTICALS, INC.","symbol":"RXRX"},"owners":[{"id":40978,"kind":"person","name":"Gibson Christopher","position":1,"cik":"0001856369","reported_name":"Gibson Christopher","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class B Common Stock","published_at":"2026-02-06T22:53:41.000Z","date":"2026-02-04","kind":"exercise","planned":true,"acquired":false,"shares":40000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each share of Class B Common Stock is convertible into one share of Class A Common Stock at the option of the holder and has no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each share of Class B Common Stock is convertible into one share of Class A Common Stock at the option of the holder and has no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each share of Class B Common Stock is convertible into one share of Class A Common Stock at the option of the holder and has no expiration date."}],"balance_after":4583334,"derivative":{"exercise_price":0,"underlying":"Class A Common Stock","underlying_shares":40000},"source":{"system":"sec-edgar","filing":"0001601830-26-000008","document":"wk-form4_1770418417.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1856369/000160183026000008/wk-form4_1770418417.xml","form_type":"4"}},{"id":916115,"issuer":{"id":1008,"kind":"organization","name":"RECURSION PHARMACEUTICALS, INC.","symbol":"RXRX"},"owners":[{"id":40978,"kind":"person","name":"Gibson Christopher","position":1,"cik":"0001856369","reported_name":"Gibson Christopher","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2026-02-06T22:53:41.000Z","date":"2026-02-06","kind":"tax_withholding","planned":true,"acquired":false,"shares":10364,"price":3.56,"value":36895.84,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F4","text":"Represents shares that have been withheld by the Issuer to satisfy its tax withholding and remittance obligations in connection with the net settlement of restricted stock units."}],"balance_after":933821,"source":{"system":"sec-edgar","filing":"0001601830-26-000008","document":"wk-form4_1770418417.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1856369/000160183026000008/wk-form4_1770418417.xml","form_type":"4"}},{"id":916114,"issuer":{"id":1008,"kind":"organization","name":"RECURSION PHARMACEUTICALS, INC.","symbol":"RXRX"},"owners":[{"id":40978,"kind":"person","name":"Gibson Christopher","position":1,"cik":"0001856369","reported_name":"Gibson Christopher","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2026-02-06T22:53:41.000Z","date":"2026-02-06","kind":"grant","planned":true,"acquired":true,"shares":30346,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"This RSU vested immediately upon the grant date."}],"balance_after":944185,"source":{"system":"sec-edgar","filing":"0001601830-26-000008","document":"wk-form4_1770418417.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1856369/000160183026000008/wk-form4_1770418417.xml","form_type":"4"}},{"id":916113,"issuer":{"id":1008,"kind":"organization","name":"RECURSION PHARMACEUTICALS, INC.","symbol":"RXRX"},"owners":[{"id":40978,"kind":"person","name":"Gibson Christopher","position":1,"cik":"0001856369","reported_name":"Gibson Christopher","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2026-02-06T22:53:41.000Z","date":"2026-02-04","kind":"sale","planned":true,"acquired":false,"shares":40000,"price":4.12,"value":164800.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"This transaction is pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 12, 2025."}],"balance_after":913839,"source":{"system":"sec-edgar","filing":"0001601830-26-000008","document":"wk-form4_1770418417.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1856369/000160183026000008/wk-form4_1770418417.xml","form_type":"4"}},{"id":916112,"issuer":{"id":1008,"kind":"organization","name":"RECURSION PHARMACEUTICALS, INC.","symbol":"RXRX"},"owners":[{"id":40978,"kind":"person","name":"Gibson Christopher","position":1,"cik":"0001856369","reported_name":"Gibson Christopher","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2026-02-06T22:53:41.000Z","date":"2026-02-04","kind":"exercise","planned":true,"acquired":true,"shares":40000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Each share of Class B Common Stock is convertible into one share of Class A Common Stock at the option of the holder and has no expiration date."},{"field":"kind","element":"transactionCoding","label":"F2","text":"This transaction is pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 12, 2025."}],"balance_after":953839,"source":{"system":"sec-edgar","filing":"0001601830-26-000008","document":"wk-form4_1770418417.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1856369/000160183026000008/wk-form4_1770418417.xml","form_type":"4"}},{"id":933477,"issuer":{"id":1008,"kind":"organization","name":"RECURSION PHARMACEUTICALS, INC.","symbol":"RXRX"},"owners":[{"id":40978,"kind":"person","name":"Gibson Christopher","position":1,"cik":"0001856369","reported_name":"Gibson Christopher","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class B Common Stock","published_at":"2026-01-23T00:34:42.000Z","date":"2026-01-20","kind":"exercise","planned":true,"acquired":false,"shares":40000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each share of Class B Common Stock is convertible into one share of Class A Common Stock at the option of the holder and has no expiration date."},{"field":"kind","element":"transactionCoding","label":"F1","text":"Each share of Class B Common Stock is convertible into one share of Class A Common Stock at the option of the holder and has no expiration date."},{"field":"kind","element":"transactionCoding","label":"F2","text":"This transaction is pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 12, 2025."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each share of Class B Common Stock is convertible into one share of Class A Common Stock at the option of the holder and has no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each share of Class B Common Stock is convertible into one share of Class A Common Stock at the option of the holder and has no expiration date."}],"balance_after":4623334,"derivative":{"exercise_price":0,"underlying":"Class A Common Stock","underlying_shares":40000},"source":{"system":"sec-edgar","filing":"0001856369-26-000005","document":"wk-form4_1769128479.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1856369/000185636926000005/wk-form4_1769128479.xml","form_type":"4"}},{"id":933476,"issuer":{"id":1008,"kind":"organization","name":"RECURSION PHARMACEUTICALS, INC.","symbol":"RXRX"},"owners":[{"id":40978,"kind":"person","name":"Gibson Christopher","position":1,"cik":"0001856369","reported_name":"Gibson Christopher","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2026-01-23T00:34:42.000Z","date":"2026-01-20","kind":"sale","planned":true,"acquired":false,"shares":40000,"price":4.47,"value":178800.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"This transaction is pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 12, 2025."}],"balance_after":913839,"source":{"system":"sec-edgar","filing":"0001856369-26-000005","document":"wk-form4_1769128479.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1856369/000185636926000005/wk-form4_1769128479.xml","form_type":"4"}},{"id":933475,"issuer":{"id":1008,"kind":"organization","name":"RECURSION PHARMACEUTICALS, INC.","symbol":"RXRX"},"owners":[{"id":40978,"kind":"person","name":"Gibson Christopher","position":1,"cik":"0001856369","reported_name":"Gibson Christopher","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2026-01-23T00:34:42.000Z","date":"2026-01-20","kind":"exercise","planned":true,"acquired":true,"shares":40000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Each share of Class B Common Stock is convertible into one share of Class A Common Stock at the option of the holder and has no expiration date."},{"field":"kind","element":"transactionCoding","label":"F2","text":"This transaction is pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 12, 2025."}],"balance_after":953839,"source":{"system":"sec-edgar","filing":"0001856369-26-000005","document":"wk-form4_1769128479.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1856369/000185636926000005/wk-form4_1769128479.xml","form_type":"4"}},{"id":944674,"issuer":{"id":1008,"kind":"organization","name":"RECURSION PHARMACEUTICALS, INC.","symbol":"RXRX"},"owners":[{"id":40978,"kind":"person","name":"Gibson Christopher","position":1,"cik":"0001856369","reported_name":"Gibson Christopher","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class B Common Stock","published_at":"2026-01-07T22:04:26.000Z","date":"2026-01-05","kind":"exercise","planned":true,"acquired":false,"shares":60000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each share of Class B Common Stock is convertible into one share of Class A Common Stock at the option of the holder and has no expiration date."},{"field":"kind","element":"transactionCoding","label":"F1","text":"Each share of Class B Common Stock is convertible into one share of Class A Common Stock at the option of the holder and has no expiration date."},{"field":"kind","element":"transactionCoding","label":"F2","text":"This transaction is pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 12, 2025."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each share of Class B Common Stock is convertible into one share of Class A Common Stock at the option of the holder and has no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each share of Class B Common Stock is convertible into one share of Class A Common Stock at the option of the holder and has no expiration date."}],"balance_after":4663334,"derivative":{"exercise_price":0,"underlying":"Class A Common Stock","underlying_shares":60000},"source":{"system":"sec-edgar","filing":"0001856369-26-000003","document":"wk-form4_1767823462.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1856369/000185636926000003/wk-form4_1767823462.xml","form_type":"4"}},{"id":944673,"issuer":{"id":1008,"kind":"organization","name":"RECURSION PHARMACEUTICALS, INC.","symbol":"RXRX"},"owners":[{"id":40978,"kind":"person","name":"Gibson Christopher","position":1,"cik":"0001856369","reported_name":"Gibson Christopher","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2026-01-07T22:04:26.000Z","date":"2026-01-05","kind":"gift","planned":true,"acquired":false,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"This transaction is pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 12, 2025."}],"balance_after":913839,"source":{"system":"sec-edgar","filing":"0001856369-26-000003","document":"wk-form4_1767823462.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1856369/000185636926000003/wk-form4_1767823462.xml","form_type":"4"}},{"id":944672,"issuer":{"id":1008,"kind":"organization","name":"RECURSION PHARMACEUTICALS, INC.","symbol":"RXRX"},"owners":[{"id":40978,"kind":"person","name":"Gibson Christopher","position":1,"cik":"0001856369","reported_name":"Gibson Christopher","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2026-01-07T22:04:26.000Z","date":"2026-01-05","kind":"sale","planned":true,"acquired":false,"shares":40000,"price":4.25,"value":170000.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"This transaction is pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 12, 2025."}],"balance_after":933839,"source":{"system":"sec-edgar","filing":"0001856369-26-000003","document":"wk-form4_1767823462.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1856369/000185636926000003/wk-form4_1767823462.xml","form_type":"4"}},{"id":944671,"issuer":{"id":1008,"kind":"organization","name":"RECURSION PHARMACEUTICALS, INC.","symbol":"RXRX"},"owners":[{"id":40978,"kind":"person","name":"Gibson Christopher","position":1,"cik":"0001856369","reported_name":"Gibson Christopher","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2026-01-07T22:04:26.000Z","date":"2026-01-05","kind":"exercise","planned":true,"acquired":true,"shares":60000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Each share of Class B Common Stock is convertible into one share of Class A Common Stock at the option of the holder and has no expiration date."},{"field":"kind","element":"transactionCoding","label":"F2","text":"This transaction is pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 12, 2025."}],"balance_after":973839,"source":{"system":"sec-edgar","filing":"0001856369-26-000003","document":"wk-form4_1767823462.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1856369/000185636926000003/wk-form4_1767823462.xml","form_type":"4"}},{"id":962120,"issuer":{"id":1008,"kind":"organization","name":"RECURSION PHARMACEUTICALS, INC.","symbol":"RXRX"},"owners":[{"id":40978,"kind":"person","name":"Gibson Christopher","position":1,"cik":"0001856369","reported_name":"Gibson Christopher","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Class B Common Stock","published_at":"2025-12-19T22:04:55.000Z","date":"2025-12-19","kind":"exercise","planned":true,"acquired":false,"shares":40000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each share of Class B Common Stock is convertible into one share of Class A Common Stock at the option of the holder and has no expiration date."},{"field":"kind","element":"transactionCoding","label":"F1","text":"Each share of Class B Common Stock is convertible into one share of Class A Common Stock at the option of the holder and has no expiration date."},{"field":"kind","element":"transactionCoding","label":"F2","text":"This transaction is pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 12, 2025."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each share of Class B Common Stock is convertible into one share of Class A Common Stock at the option of the holder and has no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each share of Class B Common Stock is convertible into one share of Class A Common Stock at the option of the holder and has no expiration date."}],"balance_after":4723334,"derivative":{"exercise_price":0,"underlying":"Class A Common Stock","underlying_shares":40000},"source":{"system":"sec-edgar","filing":"0001856369-25-000018","document":"wk-form4_1766181892.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1856369/000185636925000018/wk-form4_1766181892.xml","form_type":"4"}},{"id":962119,"issuer":{"id":1008,"kind":"organization","name":"RECURSION PHARMACEUTICALS, INC.","symbol":"RXRX"},"owners":[{"id":40978,"kind":"person","name":"Gibson Christopher","position":1,"cik":"0001856369","reported_name":"Gibson Christopher","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Class A Common Stock","published_at":"2025-12-19T22:04:55.000Z","date":"2025-12-19","kind":"sale","planned":true,"acquired":false,"shares":40000,"price":4.5,"value":180000.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"This transaction is pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 12, 2025."}],"balance_after":913839,"source":{"system":"sec-edgar","filing":"0001856369-25-000018","document":"wk-form4_1766181892.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1856369/000185636925000018/wk-form4_1766181892.xml","form_type":"4"}},{"id":962118,"issuer":{"id":1008,"kind":"organization","name":"RECURSION PHARMACEUTICALS, INC.","symbol":"RXRX"},"owners":[{"id":40978,"kind":"person","name":"Gibson Christopher","position":1,"cik":"0001856369","reported_name":"Gibson Christopher","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Class A Common Stock","published_at":"2025-12-19T22:04:55.000Z","date":"2025-12-19","kind":"exercise","planned":true,"acquired":true,"shares":40000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Each share of Class B Common Stock is convertible into one share of Class A Common Stock at the option of the holder and has no expiration date."},{"field":"kind","element":"transactionCoding","label":"F2","text":"This transaction is pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 12, 2025."}],"balance_after":953839,"source":{"system":"sec-edgar","filing":"0001856369-25-000018","document":"wk-form4_1766181892.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1856369/000185636925000018/wk-form4_1766181892.xml","form_type":"4"}},{"id":979166,"issuer":{"id":1008,"kind":"organization","name":"RECURSION PHARMACEUTICALS, INC.","symbol":"RXRX"},"owners":[{"id":40978,"kind":"person","name":"Gibson Christopher","position":1,"cik":"0001856369","reported_name":"Gibson Christopher","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Class B Common Stock","published_at":"2025-12-06T00:20:09.000Z","date":"2025-12-04","kind":"exercise","planned":true,"acquired":false,"shares":60000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Each share of Class B Common Stock is convertible into one share of Class A Common Stock at the option of the holder and has no expiration date."},{"field":"kind","element":"transactionCoding","label":"F2","text":"This transaction is pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 12, 2025."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each share of Class B Common Stock is convertible into one share of Class A Common Stock at the option of the holder and has no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each share of Class B Common Stock is convertible into one share of Class A Common Stock at the option of the holder and has no expiration date."}],"balance_after":4763334,"derivative":{"exercise_price":0,"underlying":"Class A Common Stock","underlying_shares":60000},"source":{"system":"sec-edgar","filing":"0001856369-25-000016","document":"wk-form4_1764980406.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1856369/000185636925000016/wk-form4_1764980406.xml","form_type":"4"}},{"id":979165,"issuer":{"id":1008,"kind":"organization","name":"RECURSION PHARMACEUTICALS, INC.","symbol":"RXRX"},"owners":[{"id":40978,"kind":"person","name":"Gibson Christopher","position":1,"cik":"0001856369","reported_name":"Gibson Christopher","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Class A Common Stock","published_at":"2025-12-06T00:20:09.000Z","date":"2025-12-04","kind":"gift","planned":true,"acquired":false,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"This transaction is pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 12, 2025."}],"balance_after":913839,"source":{"system":"sec-edgar","filing":"0001856369-25-000016","document":"wk-form4_1764980406.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1856369/000185636925000016/wk-form4_1764980406.xml","form_type":"4"}},{"id":979164,"issuer":{"id":1008,"kind":"organization","name":"RECURSION PHARMACEUTICALS, INC.","symbol":"RXRX"},"owners":[{"id":40978,"kind":"person","name":"Gibson Christopher","position":1,"cik":"0001856369","reported_name":"Gibson Christopher","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Class A Common Stock","published_at":"2025-12-06T00:20:09.000Z","date":"2025-12-04","kind":"sale","planned":true,"acquired":false,"shares":40000,"price":4.63,"value":185200.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"This transaction is pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 12, 2025."}],"balance_after":933839,"source":{"system":"sec-edgar","filing":"0001856369-25-000016","document":"wk-form4_1764980406.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1856369/000185636925000016/wk-form4_1764980406.xml","form_type":"4"}},{"id":979163,"issuer":{"id":1008,"kind":"organization","name":"RECURSION PHARMACEUTICALS, INC.","symbol":"RXRX"},"owners":[{"id":40978,"kind":"person","name":"Gibson Christopher","position":1,"cik":"0001856369","reported_name":"Gibson Christopher","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Class A Common Stock","published_at":"2025-12-06T00:20:09.000Z","date":"2025-12-04","kind":"exercise","planned":true,"acquired":true,"shares":60000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Each share of Class B Common Stock is convertible into one share of Class A Common Stock at the option of the holder and has no expiration date."},{"field":"kind","element":"transactionCoding","label":"F2","text":"This transaction is pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 12, 2025."}],"balance_after":973839,"source":{"system":"sec-edgar","filing":"0001856369-25-000016","document":"wk-form4_1764980406.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1856369/000185636925000016/wk-form4_1764980406.xml","form_type":"4"}},{"id":993985,"issuer":{"id":1008,"kind":"organization","name":"RECURSION PHARMACEUTICALS, INC.","symbol":"RXRX"},"owners":[{"id":40978,"kind":"person","name":"Gibson Christopher","position":1,"cik":"0001856369","reported_name":"Gibson Christopher","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Class B Common Stock","published_at":"2025-11-20T00:37:27.000Z","date":"2025-11-19","kind":"exercise","planned":true,"acquired":false,"shares":40000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Each share of Class B Common Stock is convertible into one share of Class A Common Stock at the option of the holder and has no expiration date."},{"field":"kind","element":"transactionCoding","label":"F2","text":"This transaction is pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 12, 2025."},{"field":"kind","element":"transactionCoding","label":"F3","text":"Each share of Class B Common Stock is convertible into one share of Class A Common Stock at the option of the holder and has no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Each share of Class B Common Stock is convertible into one share of Class A Common Stock at the option of the holder and has no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Each share of Class B Common Stock is convertible into one share of Class A Common Stock at the option of the holder and has no expiration date."}],"balance_after":4823334,"derivative":{"exercise_price":0,"underlying":"Class A Common Stock","underlying_shares":40000},"source":{"system":"sec-edgar","filing":"0001856369-25-000014","document":"wk-form4_1763599043.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1856369/000185636925000014/wk-form4_1763599043.xml","form_type":"4"}},{"id":993984,"issuer":{"id":1008,"kind":"organization","name":"RECURSION PHARMACEUTICALS, INC.","symbol":"RXRX"},"owners":[{"id":40978,"kind":"person","name":"Gibson Christopher","position":1,"cik":"0001856369","reported_name":"Gibson Christopher","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Class A Common Stock","published_at":"2025-11-20T00:37:27.000Z","date":"2025-11-19","kind":"sale","planned":true,"acquired":false,"shares":40000,"price":4.16,"value":166400.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"This transaction is pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 12, 2025."}],"balance_after":913839,"source":{"system":"sec-edgar","filing":"0001856369-25-000014","document":"wk-form4_1763599043.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1856369/000185636925000014/wk-form4_1763599043.xml","form_type":"4"}},{"id":993983,"issuer":{"id":1008,"kind":"organization","name":"RECURSION PHARMACEUTICALS, INC.","symbol":"RXRX"},"owners":[{"id":40978,"kind":"person","name":"Gibson Christopher","position":1,"cik":"0001856369","reported_name":"Gibson Christopher","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Class A Common Stock","published_at":"2025-11-20T00:37:27.000Z","date":"2025-11-19","kind":"exercise","planned":true,"acquired":true,"shares":40000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"This transaction is pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 12, 2025."},{"field":"kind","element":"transactionCoding","label":"F3","text":"Each share of Class B Common Stock is convertible into one share of Class A Common Stock at the option of the holder and has no expiration date."}],"balance_after":953839,"source":{"system":"sec-edgar","filing":"0001856369-25-000014","document":"wk-form4_1763599043.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1856369/000185636925000014/wk-form4_1763599043.xml","form_type":"4"}},{"id":993982,"issuer":{"id":1008,"kind":"organization","name":"RECURSION PHARMACEUTICALS, INC.","symbol":"RXRX"},"owners":[{"id":40978,"kind":"person","name":"Gibson Christopher","position":1,"cik":"0001856369","reported_name":"Gibson Christopher","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Class A Common Stock","published_at":"2025-11-20T00:37:27.000Z","date":"2025-11-17","kind":"tax_withholding","planned":true,"acquired":false,"shares":40390,"price":4.14,"value":167214.6,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares that have been withheld by the Issuer to satisfy its tax withholding and remittance obligations in connection with the net settlement of restricted stock units."}],"balance_after":913839,"source":{"system":"sec-edgar","filing":"0001856369-25-000014","document":"wk-form4_1763599043.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1856369/000185636925000014/wk-form4_1763599043.xml","form_type":"4"}},{"id":1005878,"issuer":{"id":1008,"kind":"organization","name":"RECURSION PHARMACEUTICALS, INC.","symbol":"RXRX"},"owners":[{"id":40978,"kind":"person","name":"Gibson Christopher","position":1,"cik":"0001856369","reported_name":"Gibson Christopher","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Class B Common Stock","published_at":"2025-11-06T21:23:45.000Z","date":"2025-11-04","kind":"exercise","planned":true,"acquired":false,"shares":60000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Each share of Class B Common Stock is convertible into one share of Class A Common Stock at the option of the holder and has no expiration date."},{"field":"kind","element":"transactionCoding","label":"F2","text":"This transaction is pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 12, 2025."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each share of Class B Common Stock is convertible into one share of Class A Common Stock at the option of the holder and has no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each share of Class B Common Stock is convertible into one share of Class A Common Stock at the option of the holder and has no expiration date."}],"balance_after":4863334,"derivative":{"exercise_price":0,"underlying":"Class A Common Stock","underlying_shares":60000},"source":{"system":"sec-edgar","filing":"0001856369-25-000012","document":"wk-form4_1762464222.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1856369/000185636925000012/wk-form4_1762464222.xml","form_type":"4"}},{"id":1005877,"issuer":{"id":1008,"kind":"organization","name":"RECURSION PHARMACEUTICALS, INC.","symbol":"RXRX"},"owners":[{"id":40978,"kind":"person","name":"Gibson Christopher","position":1,"cik":"0001856369","reported_name":"Gibson Christopher","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Class A Common Stock","published_at":"2025-11-06T21:23:45.000Z","date":"2025-11-04","kind":"gift","planned":true,"acquired":false,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"This transaction is pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 12, 2025."}],"balance_after":954229,"source":{"system":"sec-edgar","filing":"0001856369-25-000012","document":"wk-form4_1762464222.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1856369/000185636925000012/wk-form4_1762464222.xml","form_type":"4"}},{"id":1005876,"issuer":{"id":1008,"kind":"organization","name":"RECURSION PHARMACEUTICALS, INC.","symbol":"RXRX"},"owners":[{"id":40978,"kind":"person","name":"Gibson Christopher","position":1,"cik":"0001856369","reported_name":"Gibson Christopher","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Class A Common Stock","published_at":"2025-11-06T21:23:45.000Z","date":"2025-11-04","kind":"sale","planned":true,"acquired":false,"shares":40000,"price":5.21,"value":208400.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"This transaction is pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 12, 2025."}],"balance_after":974229,"source":{"system":"sec-edgar","filing":"0001856369-25-000012","document":"wk-form4_1762464222.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1856369/000185636925000012/wk-form4_1762464222.xml","form_type":"4"}},{"id":1005875,"issuer":{"id":1008,"kind":"organization","name":"RECURSION PHARMACEUTICALS, INC.","symbol":"RXRX"},"owners":[{"id":40978,"kind":"person","name":"Gibson Christopher","position":1,"cik":"0001856369","reported_name":"Gibson Christopher","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Class A Common Stock","published_at":"2025-11-06T21:23:45.000Z","date":"2025-11-04","kind":"exercise","planned":true,"acquired":true,"shares":60000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Each share of Class B Common Stock is convertible into one share of Class A Common Stock at the option of the holder and has no expiration date."},{"field":"kind","element":"transactionCoding","label":"F2","text":"This transaction is pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 12, 2025."}],"balance_after":1014229,"source":{"system":"sec-edgar","filing":"0001856369-25-000012","document":"wk-form4_1762464222.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1856369/000185636925000012/wk-form4_1762464222.xml","form_type":"4"}},{"id":1013864,"issuer":{"id":1008,"kind":"organization","name":"RECURSION PHARMACEUTICALS, INC.","symbol":"RXRX"},"owners":[{"id":40978,"kind":"person","name":"Gibson Christopher","position":1,"cik":"0001856369","reported_name":"Gibson Christopher","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Class B Common Stock","published_at":"2025-10-24T22:49:01.000Z","date":"2025-10-23","kind":"exercise","planned":true,"acquired":false,"shares":100000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Each share of Class B Common Stock is convertible into one share of Class A Common Stock at the option of the holder and has no expiration date."},{"field":"kind","element":"transactionCoding","label":"F2","text":"This transaction is pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 12, 2025."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each share of Class B Common Stock is convertible into one share of Class A Common Stock at the option of the holder and has no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each share of Class B Common Stock is convertible into one share of Class A Common Stock at the option of the holder and has no expiration date."}],"balance_after":4923334,"derivative":{"exercise_price":0,"underlying":"Class A Common Stock","underlying_shares":100000},"source":{"system":"sec-edgar","filing":"0001856369-25-000010","document":"wk-form4_1761346138.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1856369/000185636925000010/wk-form4_1761346138.xml","form_type":"4"}},{"id":1013863,"issuer":{"id":1008,"kind":"organization","name":"RECURSION PHARMACEUTICALS, INC.","symbol":"RXRX"},"owners":[{"id":40978,"kind":"person","name":"Gibson Christopher","position":1,"cik":"0001856369","reported_name":"Gibson Christopher","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Class A Common Stock","published_at":"2025-10-24T22:49:01.000Z","date":"2025-10-23","kind":"sale","planned":true,"acquired":false,"shares":100000,"price":5.7,"value":570000.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"This transaction is pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 12, 2025."}],"balance_after":954229,"source":{"system":"sec-edgar","filing":"0001856369-25-000010","document":"wk-form4_1761346138.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1856369/000185636925000010/wk-form4_1761346138.xml","form_type":"4"}},{"id":1013862,"issuer":{"id":1008,"kind":"organization","name":"RECURSION PHARMACEUTICALS, INC.","symbol":"RXRX"},"owners":[{"id":40978,"kind":"person","name":"Gibson Christopher","position":1,"cik":"0001856369","reported_name":"Gibson Christopher","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Class A Common Stock","published_at":"2025-10-24T22:49:01.000Z","date":"2025-10-23","kind":"exercise","planned":true,"acquired":true,"shares":100000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Each share of Class B Common Stock is convertible into one share of Class A Common Stock at the option of the holder and has no expiration date."},{"field":"kind","element":"transactionCoding","label":"F2","text":"This transaction is pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 12, 2025."}],"balance_after":1054229,"source":{"system":"sec-edgar","filing":"0001856369-25-000010","document":"wk-form4_1761346138.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1856369/000185636925000010/wk-form4_1761346138.xml","form_type":"4"}},{"id":1020336,"issuer":{"id":1008,"kind":"organization","name":"RECURSION PHARMACEUTICALS, INC.","symbol":"RXRX"},"owners":[{"id":40978,"kind":"person","name":"Gibson Christopher","position":1,"cik":"0001856369","reported_name":"Gibson Christopher","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Class B Common Stock","published_at":"2025-10-10T22:03:11.000Z","date":"2025-10-10","kind":"exercise","planned":true,"acquired":false,"shares":120000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Each share of Class B Common Stock is convertible into one share of Class A Common Stock at the option of the holder and has no expiration date."},{"field":"kind","element":"transactionCoding","label":"F2","text":"This transaction is pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 12, 2025."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each share of Class B Common Stock is convertible into one share of Class A Common Stock at the option of the holder and has no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each share of Class B Common Stock is convertible into one share of Class A Common Stock at the option of the holder and has no expiration date."}],"balance_after":5133034,"derivative":{"exercise_price":0,"underlying":"Class A Common Stock","underlying_shares":120000},"source":{"system":"sec-edgar","filing":"0001856369-25-000007","document":"wk-form4_1760133788.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1856369/000185636925000007/wk-form4_1760133788.xml","form_type":"4"}},{"id":1020335,"issuer":{"id":1008,"kind":"organization","name":"RECURSION PHARMACEUTICALS, INC.","symbol":"RXRX"},"owners":[{"id":40978,"kind":"person","name":"Gibson Christopher","position":1,"cik":"0001856369","reported_name":"Gibson Christopher","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Class A Common Stock","published_at":"2025-10-10T22:03:11.000Z","date":"2025-10-10","kind":"gift","planned":true,"acquired":false,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"This transaction is pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 12, 2025."}],"balance_after":954229,"source":{"system":"sec-edgar","filing":"0001856369-25-000007","document":"wk-form4_1760133788.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1856369/000185636925000007/wk-form4_1760133788.xml","form_type":"4"}},{"id":1020334,"issuer":{"id":1008,"kind":"organization","name":"RECURSION PHARMACEUTICALS, INC.","symbol":"RXRX"},"owners":[{"id":40978,"kind":"person","name":"Gibson Christopher","position":1,"cik":"0001856369","reported_name":"Gibson Christopher","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Class A Common Stock","published_at":"2025-10-10T22:03:11.000Z","date":"2025-10-10","kind":"sale","planned":true,"acquired":false,"shares":100000,"price":6.04,"value":604000.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"This transaction is pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 12, 2025."}],"balance_after":974229,"source":{"system":"sec-edgar","filing":"0001856369-25-000007","document":"wk-form4_1760133788.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1856369/000185636925000007/wk-form4_1760133788.xml","form_type":"4"}},{"id":1020333,"issuer":{"id":1008,"kind":"organization","name":"RECURSION PHARMACEUTICALS, INC.","symbol":"RXRX"},"owners":[{"id":40978,"kind":"person","name":"Gibson Christopher","position":1,"cik":"0001856369","reported_name":"Gibson Christopher","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Class A Common Stock","published_at":"2025-10-10T22:03:11.000Z","date":"2025-10-10","kind":"exercise","planned":true,"acquired":true,"shares":120000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Each share of Class B Common Stock is convertible into one share of Class A Common Stock at the option of the holder and has no expiration date."},{"field":"kind","element":"transactionCoding","label":"F2","text":"This transaction is pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 12, 2025."}],"balance_after":1074229,"source":{"system":"sec-edgar","filing":"0001856369-25-000007","document":"wk-form4_1760133788.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1856369/000185636925000007/wk-form4_1760133788.xml","form_type":"4"}},{"id":1031795,"issuer":{"id":1008,"kind":"organization","name":"RECURSION PHARMACEUTICALS, INC.","symbol":"RXRX"},"owners":[{"id":40978,"kind":"person","name":"Gibson Christopher","position":1,"cik":"0001856369","reported_name":"Gibson Christopher","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Class B Common Stock","published_at":"2025-09-26T22:32:01.000Z","date":"2025-09-25","kind":"exercise","planned":true,"acquired":false,"shares":0,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Each share of Class B Common Stock is convertible into one share of Class A Common Stock at the option of the holder and has no expiration date."},{"field":"kind","element":"transactionCoding","label":"F2","text":"This transaction is pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 12, 2025."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each share of Class B Common Stock is convertible into one share of Class A Common Stock at the option of the holder and has no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each share of Class B Common Stock is convertible into one share of Class A Common Stock at the option of the holder and has no expiration date."}],"balance_after":5253034,"derivative":{"exercise_price":0,"underlying":"Class A Common Stock","underlying_shares":100000},"source":{"system":"sec-edgar","filing":"0001856369-25-000005","document":"wk-form4_1758925918.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1856369/000185636925000005/wk-form4_1758925918.xml","form_type":"4"}},{"id":1031794,"issuer":{"id":1008,"kind":"organization","name":"RECURSION PHARMACEUTICALS, INC.","symbol":"RXRX"},"owners":[{"id":40978,"kind":"person","name":"Gibson Christopher","position":1,"cik":"0001856369","reported_name":"Gibson Christopher","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Class A Common Stock","published_at":"2025-09-26T22:32:01.000Z","date":"2025-09-25","kind":"sale","planned":true,"acquired":false,"shares":100000,"price":4.76,"value":476000.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"This transaction is pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 12, 2025."}],"balance_after":954229,"source":{"system":"sec-edgar","filing":"0001856369-25-000005","document":"wk-form4_1758925918.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1856369/000185636925000005/wk-form4_1758925918.xml","form_type":"4"}},{"id":1031793,"issuer":{"id":1008,"kind":"organization","name":"RECURSION PHARMACEUTICALS, INC.","symbol":"RXRX"},"owners":[{"id":40978,"kind":"person","name":"Gibson Christopher","position":1,"cik":"0001856369","reported_name":"Gibson Christopher","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Class A Common Stock","published_at":"2025-09-26T22:32:01.000Z","date":"2025-09-25","kind":"exercise","planned":true,"acquired":true,"shares":100000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Each share of Class B Common Stock is convertible into one share of Class A Common Stock at the option of the holder and has no expiration date."},{"field":"kind","element":"transactionCoding","label":"F2","text":"This transaction is pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 12, 2025."}],"balance_after":1054229,"source":{"system":"sec-edgar","filing":"0001856369-25-000005","document":"wk-form4_1758925918.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1856369/000185636925000005/wk-form4_1758925918.xml","form_type":"4"}},{"id":1041684,"issuer":{"id":1008,"kind":"organization","name":"RECURSION PHARMACEUTICALS, INC.","symbol":"RXRX"},"owners":[{"id":40978,"kind":"person","name":"Gibson Christopher","position":1,"cik":"0001856369","reported_name":"Gibson Christopher","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Class B Common Stock","published_at":"2025-09-12T20:24:04.000Z","date":"2025-09-10","kind":"exercise","planned":true,"acquired":false,"shares":120000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Each share of Class B Common Stock is convertible into one share of Class A Common Stock at the option of the holder and has no expiration date."},{"field":"kind","element":"transactionCoding","label":"F2","text":"This transaction is pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 12, 2025."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each share of Class B Common Stock is convertible into one share of Class A Common Stock at the option of the holder and has no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each share of Class B Common Stock is convertible into one share of Class A Common Stock at the option of the holder and has no expiration date."}],"balance_after":5253034,"derivative":{"exercise_price":0,"underlying":"Class A Common Stock","underlying_shares":120000},"source":{"system":"sec-edgar","filing":"0001601830-25-000145","document":"wk-form4_1757708640.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1856369/000160183025000145/wk-form4_1757708640.xml","form_type":"4"}},{"id":1041683,"issuer":{"id":1008,"kind":"organization","name":"RECURSION PHARMACEUTICALS, INC.","symbol":"RXRX"},"owners":[{"id":40978,"kind":"person","name":"Gibson Christopher","position":1,"cik":"0001856369","reported_name":"Gibson Christopher","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Class A Common Stock","published_at":"2025-09-12T20:24:04.000Z","date":"2025-09-10","kind":"gift","planned":true,"acquired":false,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"This transaction is pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 12, 2025."},{"field":"kind","element":"transactionCoding","label":"F3","text":"Represents the automatic conversion of Class B Common Stock into Class A Common Stock in connection with a bona-fide gift of shares by the Reporting Person."}],"balance_after":954229,"source":{"system":"sec-edgar","filing":"0001601830-25-000145","document":"wk-form4_1757708640.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1856369/000160183025000145/wk-form4_1757708640.xml","form_type":"4"}},{"id":1041682,"issuer":{"id":1008,"kind":"organization","name":"RECURSION PHARMACEUTICALS, INC.","symbol":"RXRX"},"owners":[{"id":40978,"kind":"person","name":"Gibson Christopher","position":1,"cik":"0001856369","reported_name":"Gibson Christopher","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Class A Common Stock","published_at":"2025-09-12T20:24:04.000Z","date":"2025-09-10","kind":"sale","planned":true,"acquired":false,"shares":100000,"price":4.71,"value":471000.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"This transaction is pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 12, 2025."}],"balance_after":974229,"source":{"system":"sec-edgar","filing":"0001601830-25-000145","document":"wk-form4_1757708640.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1856369/000160183025000145/wk-form4_1757708640.xml","form_type":"4"}},{"id":1041681,"issuer":{"id":1008,"kind":"organization","name":"RECURSION PHARMACEUTICALS, INC.","symbol":"RXRX"},"owners":[{"id":40978,"kind":"person","name":"Gibson Christopher","position":1,"cik":"0001856369","reported_name":"Gibson Christopher","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Class A Common Stock","published_at":"2025-09-12T20:24:04.000Z","date":"2025-09-10","kind":"exercise","planned":true,"acquired":true,"shares":120000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Each share of Class B Common Stock is convertible into one share of Class A Common Stock at the option of the holder and has no expiration date."},{"field":"kind","element":"transactionCoding","label":"F2","text":"This transaction is pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 12, 2025."}],"balance_after":1074229,"source":{"system":"sec-edgar","filing":"0001601830-25-000145","document":"wk-form4_1757708640.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1856369/000160183025000145/wk-form4_1757708640.xml","form_type":"4"}},{"id":1053703,"issuer":{"id":1008,"kind":"organization","name":"RECURSION PHARMACEUTICALS, INC.","symbol":"RXRX"},"owners":[{"id":40978,"kind":"person","name":"Gibson Christopher","position":1,"cik":"0001856369","reported_name":"Gibson Christopher","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Class B Common Stock","published_at":"2025-08-29T00:00:58.000Z","date":"2025-08-26","kind":"exercise","planned":true,"acquired":false,"shares":100000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Each share of Class B Common Stock is convertible into one share of Class A Common Stock at the option of the holder and has no expiration date."},{"field":"kind","element":"transactionCoding","label":"F2","text":"This transaction is pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 12, 2025."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each share of Class B Common Stock is convertible into one share of Class A Common Stock at the option of the holder and has no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each share of Class B Common Stock is convertible into one share of Class A Common Stock at the option of the holder and has no expiration date."}],"balance_after":5373034,"derivative":{"exercise_price":0,"underlying":"Class A Common Stock","underlying_shares":100000},"source":{"system":"sec-edgar","filing":"0001601830-25-000136","document":"wk-form4_1756425654.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1856369/000160183025000136/wk-form4_1756425654.xml","form_type":"4"}},{"id":1053702,"issuer":{"id":1008,"kind":"organization","name":"RECURSION PHARMACEUTICALS, INC.","symbol":"RXRX"},"owners":[{"id":40978,"kind":"person","name":"Gibson Christopher","position":1,"cik":"0001856369","reported_name":"Gibson Christopher","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Class A Common Stock","published_at":"2025-08-29T00:00:58.000Z","date":"2025-08-26","kind":"sale","planned":true,"acquired":false,"shares":100000,"price":4.84,"value":484000.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"This transaction is pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 12, 2025."}],"balance_after":954229,"source":{"system":"sec-edgar","filing":"0001601830-25-000136","document":"wk-form4_1756425654.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1856369/000160183025000136/wk-form4_1756425654.xml","form_type":"4"}},{"id":1053701,"issuer":{"id":1008,"kind":"organization","name":"RECURSION PHARMACEUTICALS, INC.","symbol":"RXRX"},"owners":[{"id":40978,"kind":"person","name":"Gibson Christopher","position":1,"cik":"0001856369","reported_name":"Gibson Christopher","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Class A Common Stock","published_at":"2025-08-29T00:00:58.000Z","date":"2025-08-26","kind":"exercise","planned":true,"acquired":true,"shares":100000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Each share of Class B Common Stock is convertible into one share of Class A Common Stock at the option of the holder and has no expiration date."},{"field":"kind","element":"transactionCoding","label":"F2","text":"This transaction is pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 12, 2025."}],"balance_after":1054229,"source":{"system":"sec-edgar","filing":"0001601830-25-000136","document":"wk-form4_1756425654.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1856369/000160183025000136/wk-form4_1756425654.xml","form_type":"4"}},{"id":1061985,"issuer":{"id":1008,"kind":"organization","name":"RECURSION PHARMACEUTICALS, INC.","symbol":"RXRX"},"owners":[{"id":40978,"kind":"person","name":"Gibson Christopher","position":1,"cik":"0001856369","reported_name":"Gibson Christopher","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Class A Common Stock","published_at":"2025-08-19T22:22:07.000Z","date":"2025-08-15","kind":"tax_withholding","planned":false,"acquired":false,"shares":40390,"price":5.64,"value":227799.6,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares that have been withheld by the Issuer to satisfy its tax withholding and remittance obligations in connection with the net settlement of restricted stock units."}],"balance_after":954229,"source":{"system":"sec-edgar","filing":"0001601830-25-000132","document":"wk-form4_1755642123.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1856369/000160183025000132/wk-form4_1755642123.xml","form_type":"4"}},{"id":1067898,"issuer":{"id":1008,"kind":"organization","name":"RECURSION PHARMACEUTICALS, INC.","symbol":"RXRX"},"owners":[{"id":40978,"kind":"person","name":"Gibson Christopher","position":1,"cik":"0001856369","reported_name":"Gibson Christopher","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Class B Common Stock","published_at":"2025-08-14T01:03:16.000Z","date":"2025-08-11","kind":"exercise","planned":true,"acquired":false,"shares":17875,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"by Gibson Family Trust"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents the automatic conversion of Class B Common Stock into Class A Common Stock."},{"field":"kind","element":"transactionCoding","label":"F2","text":"This transaction is pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 12, 2025."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"Each share of Class B Common Stock is convertible into one share of Class A Common Stock at the option of the holder and has no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F6","text":"Each share of Class B Common Stock is convertible into one share of Class A Common Stock at the option of the holder and has no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F5","text":"The shares are held by the Gibson Family Trust, of which the Reporting Person serves as Trustee."}],"balance_after":50000,"derivative":{"exercise_price":0,"underlying":"Class A Common Stock","underlying_shares":17875},"source":{"system":"sec-edgar","filing":"0001601830-25-000130","document":"wk-form4_1755133392.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1856369/000160183025000130/wk-form4_1755133392.xml","form_type":"4"}},{"id":1067897,"issuer":{"id":1008,"kind":"organization","name":"RECURSION PHARMACEUTICALS, INC.","symbol":"RXRX"},"owners":[{"id":40978,"kind":"person","name":"Gibson Christopher","position":1,"cik":"0001856369","reported_name":"Gibson Christopher","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Class B Common Stock","published_at":"2025-08-14T01:03:16.000Z","date":"2025-08-11","kind":"exercise","planned":true,"acquired":false,"shares":100000,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"by LAHWRAN-3 LLC"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents the automatic conversion of Class B Common Stock into Class A Common Stock."},{"field":"kind","element":"transactionCoding","label":"F2","text":"This transaction is pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 12, 2025."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"Each share of Class B Common Stock is convertible into one share of Class A Common Stock at the option of the holder and has no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F6","text":"Each share of Class B Common Stock is convertible into one share of Class A Common Stock at the option of the holder and has no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"The shares are held by LAHWRAN-3 LLC, of which the Reporting Person is a member and a manager."}],"balance_after":386000,"derivative":{"exercise_price":0,"underlying":"Class A Common Stock","underlying_shares":100000},"source":{"system":"sec-edgar","filing":"0001601830-25-000130","document":"wk-form4_1755133392.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1856369/000160183025000130/wk-form4_1755133392.xml","form_type":"4"}},{"id":1067896,"issuer":{"id":1008,"kind":"organization","name":"RECURSION PHARMACEUTICALS, INC.","symbol":"RXRX"},"owners":[{"id":40978,"kind":"person","name":"Gibson Christopher","position":1,"cik":"0001856369","reported_name":"Gibson Christopher","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Class B Common Stock","published_at":"2025-08-14T01:03:16.000Z","date":"2025-08-11","kind":"exercise","planned":true,"acquired":false,"shares":423666,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents the automatic conversion of Class B Common Stock into Class A Common Stock."},{"field":"kind","element":"transactionCoding","label":"F2","text":"This transaction is pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 12, 2025."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"Each share of Class B Common Stock is convertible into one share of Class A Common Stock at the option of the holder and has no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F6","text":"Each share of Class B Common Stock is convertible into one share of Class A Common Stock at the option of the holder and has no expiration date."}],"balance_after":5473034,"derivative":{"exercise_price":0,"underlying":"Class A Common Stock","underlying_shares":423666},"source":{"system":"sec-edgar","filing":"0001601830-25-000130","document":"wk-form4_1755133392.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1856369/000160183025000130/wk-form4_1755133392.xml","form_type":"4"}},{"id":1067895,"issuer":{"id":1008,"kind":"organization","name":"RECURSION PHARMACEUTICALS, INC.","symbol":"RXRX"},"owners":[{"id":40978,"kind":"person","name":"Gibson Christopher","position":1,"cik":"0001856369","reported_name":"Gibson Christopher","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Class A Common Stock","published_at":"2025-08-14T01:03:16.000Z","date":"2025-08-11","kind":"sale","planned":true,"acquired":false,"shares":17875,"price":5.28,"value":94380.0,"ownership":{"direct":false,"nature":"by Gibson Family Trust"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"This transaction is pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 12, 2025."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F5","text":"The shares are held by the Gibson Family Trust, of which the Reporting Person serves as Trustee."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001601830-25-000130","document":"wk-form4_1755133392.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1856369/000160183025000130/wk-form4_1755133392.xml","form_type":"4"}},{"id":1067894,"issuer":{"id":1008,"kind":"organization","name":"RECURSION PHARMACEUTICALS, INC.","symbol":"RXRX"},"owners":[{"id":40978,"kind":"person","name":"Gibson Christopher","position":1,"cik":"0001856369","reported_name":"Gibson Christopher","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Class A Common Stock","published_at":"2025-08-14T01:03:16.000Z","date":"2025-08-11","kind":"exercise","planned":true,"acquired":true,"shares":17875,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"by Gibson Family Trust"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents the automatic conversion of Class B Common Stock into Class A Common Stock."},{"field":"kind","element":"transactionCoding","label":"F2","text":"This transaction is pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 12, 2025."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F5","text":"The shares are held by the Gibson Family Trust, of which the Reporting Person serves as Trustee."}],"balance_after":17875,"source":{"system":"sec-edgar","filing":"0001601830-25-000130","document":"wk-form4_1755133392.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1856369/000160183025000130/wk-form4_1755133392.xml","form_type":"4"}},{"id":1067893,"issuer":{"id":1008,"kind":"organization","name":"RECURSION PHARMACEUTICALS, INC.","symbol":"RXRX"},"owners":[{"id":40978,"kind":"person","name":"Gibson Christopher","position":1,"cik":"0001856369","reported_name":"Gibson Christopher","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Class A Common Stock","published_at":"2025-08-14T01:03:16.000Z","date":"2025-08-11","kind":"sale","planned":true,"acquired":false,"shares":100000,"price":5.28,"value":528000.0,"ownership":{"direct":false,"nature":"by LAHWRAN-3 LLC"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"This transaction is pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 12, 2025."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"The shares are held by LAHWRAN-3 LLC, of which the Reporting Person is a member and a manager."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001601830-25-000130","document":"wk-form4_1755133392.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1856369/000160183025000130/wk-form4_1755133392.xml","form_type":"4"}},{"id":1067892,"issuer":{"id":1008,"kind":"organization","name":"RECURSION PHARMACEUTICALS, INC.","symbol":"RXRX"},"owners":[{"id":40978,"kind":"person","name":"Gibson Christopher","position":1,"cik":"0001856369","reported_name":"Gibson Christopher","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Class A Common Stock","published_at":"2025-08-14T01:03:16.000Z","date":"2025-08-11","kind":"exercise","planned":true,"acquired":true,"shares":100000,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"by LAHWRAN-3 LLC"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents the automatic conversion of Class B Common Stock into Class A Common Stock."},{"field":"kind","element":"transactionCoding","label":"F2","text":"This transaction is pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 12, 2025."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"The shares are held by LAHWRAN-3 LLC, of which the Reporting Person is a member and a manager."}],"balance_after":100000,"source":{"system":"sec-edgar","filing":"0001601830-25-000130","document":"wk-form4_1755133392.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1856369/000160183025000130/wk-form4_1755133392.xml","form_type":"4"}},{"id":1067891,"issuer":{"id":1008,"kind":"organization","name":"RECURSION PHARMACEUTICALS, INC.","symbol":"RXRX"},"owners":[{"id":40978,"kind":"person","name":"Gibson Christopher","position":1,"cik":"0001856369","reported_name":"Gibson Christopher","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Class A Common Stock","published_at":"2025-08-14T01:03:16.000Z","date":"2025-08-11","kind":"gift","planned":true,"acquired":false,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"This transaction is pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 12, 2025."},{"field":"kind","element":"transactionCoding","label":"F3","text":"Represents the automatic conversion of Class B Common Stock into Class A Common Stock in connection with a bona-fide gift of shares by the Reporting Person"}],"balance_after":994619,"source":{"system":"sec-edgar","filing":"0001601830-25-000130","document":"wk-form4_1755133392.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1856369/000160183025000130/wk-form4_1755133392.xml","form_type":"4"}},{"id":1067890,"issuer":{"id":1008,"kind":"organization","name":"RECURSION PHARMACEUTICALS, INC.","symbol":"RXRX"},"owners":[{"id":40978,"kind":"person","name":"Gibson Christopher","position":1,"cik":"0001856369","reported_name":"Gibson Christopher","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Class A Common Stock","published_at":"2025-08-14T01:03:16.000Z","date":"2025-08-11","kind":"sale","planned":true,"acquired":false,"shares":500300,"price":5.28,"value":2641584.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"This transaction is pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 12, 2025."}],"balance_after":1004619,"source":{"system":"sec-edgar","filing":"0001601830-25-000130","document":"wk-form4_1755133392.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1856369/000160183025000130/wk-form4_1755133392.xml","form_type":"4"}},{"id":1067889,"issuer":{"id":1008,"kind":"organization","name":"RECURSION PHARMACEUTICALS, INC.","symbol":"RXRX"},"owners":[{"id":40978,"kind":"person","name":"Gibson Christopher","position":1,"cik":"0001856369","reported_name":"Gibson Christopher","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Class A Common Stock","published_at":"2025-08-14T01:03:16.000Z","date":"2025-08-11","kind":"exercise","planned":true,"acquired":true,"shares":423666,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents the automatic conversion of Class B Common Stock into Class A Common Stock."},{"field":"kind","element":"transactionCoding","label":"F2","text":"This transaction is pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 12, 2025."}],"balance_after":1504919,"source":{"system":"sec-edgar","filing":"0001601830-25-000130","document":"wk-form4_1755133392.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1856369/000160183025000130/wk-form4_1755133392.xml","form_type":"4"}},{"id":1142988,"issuer":{"id":1008,"kind":"organization","name":"RECURSION PHARMACEUTICALS, INC.","symbol":"RXRX"},"owners":[{"id":40978,"kind":"person","name":"Gibson Christopher","position":1,"cik":"0001856369","reported_name":"Gibson Christopher","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Class A Common Stock","published_at":"2025-05-19T20:44:03.000Z","date":"2025-05-15","kind":"tax_withholding","planned":false,"acquired":false,"shares":36197,"price":4.25,"value":153837.25,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares that have been withheld by the Issuer to satisfy its tax withholding and remittance obligations in connection with the net settlement of restricted stock units."}],"balance_after":1081253,"source":{"system":"sec-edgar","filing":"0001601830-25-000082","document":"wk-form4_1747687435.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1856369/000160183025000082/wk-form4_1747687435.xml","form_type":"4"}},{"id":1188907,"issuer":{"id":1008,"kind":"organization","name":"RECURSION PHARMACEUTICALS, INC.","symbol":"RXRX"},"owners":[{"id":40978,"kind":"person","name":"Gibson Christopher","position":1,"cik":"0001856369","reported_name":"Gibson Christopher","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Class A Common Stock","published_at":"2025-03-28T20:52:57.000Z","date":"2025-03-27","kind":"sale","planned":true,"acquired":false,"shares":138574,"price":6.04,"value":836986.96,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction is pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 19, 2024."}],"balance_after":1117450,"source":{"system":"sec-edgar","filing":"0001601830-25-000051","document":"wk-form4_1743195171.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1856369/000160183025000051/wk-form4_1743195171.xml","form_type":"4"}},{"id":1217655,"issuer":{"id":1008,"kind":"organization","name":"RECURSION PHARMACEUTICALS, INC.","symbol":"RXRX"},"owners":[{"id":40978,"kind":"person","name":"Gibson Christopher","position":1,"cik":"0001856369","reported_name":"Gibson Christopher","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Class B Common Stock","published_at":"2025-03-07T21:16:27.000Z","date":"2025-03-06","kind":"exercise","planned":true,"acquired":false,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Each share of Class B Common Stock is convertible into one share of Class A Common Stock at the option of the holder and has no expiration date."},{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents the automatic conversion of Class B Common Stock into Class A Common Stock."},{"field":"kind","element":"transactionCoding","label":"F2","text":"This transaction is pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 27, 2023."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Each share of Class B Common Stock is convertible into one share of Class A Common Stock at the option of the holder and has no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Each share of Class B Common Stock is convertible into one share of Class A Common Stock at the option of the holder and has no expiration date."}],"balance_after":5896700,"derivative":{"exercise_price":0,"underlying":"Class A Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001601830-25-000037","document":"wk-form4_1741382181.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1856369/000160183025000037/wk-form4_1741382181.xml","form_type":"4"}},{"id":1217654,"issuer":{"id":1008,"kind":"organization","name":"RECURSION PHARMACEUTICALS, INC.","symbol":"RXRX"},"owners":[{"id":40978,"kind":"person","name":"Gibson Christopher","position":1,"cik":"0001856369","reported_name":"Gibson Christopher","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Class B Common Stock","published_at":"2025-03-07T21:16:27.000Z","date":"2025-03-05","kind":"exercise","planned":true,"acquired":false,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Each share of Class B Common Stock is convertible into one share of Class A Common Stock at the option of the holder and has no expiration date."},{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents the automatic conversion of Class B Common Stock into Class A Common Stock."},{"field":"kind","element":"transactionCoding","label":"F2","text":"This transaction is pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 27, 2023."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Each share of Class B Common Stock is convertible into one share of Class A Common Stock at the option of the holder and has no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Each share of Class B Common Stock is convertible into one share of Class A Common Stock at the option of the holder and has no expiration date."}],"balance_after":5916700,"derivative":{"exercise_price":0,"underlying":"Class A Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001601830-25-000037","document":"wk-form4_1741382181.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1856369/000160183025000037/wk-form4_1741382181.xml","form_type":"4"}},{"id":1217653,"issuer":{"id":1008,"kind":"organization","name":"RECURSION PHARMACEUTICALS, INC.","symbol":"RXRX"},"owners":[{"id":40978,"kind":"person","name":"Gibson Christopher","position":1,"cik":"0001856369","reported_name":"Gibson Christopher","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Class A Common Stock","published_at":"2025-03-07T21:16:27.000Z","date":"2025-03-06","kind":"sale","planned":true,"acquired":false,"shares":20000,"price":6.37,"value":127400.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"This transaction is pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 27, 2023."}],"balance_after":1256024,"source":{"system":"sec-edgar","filing":"0001601830-25-000037","document":"wk-form4_1741382181.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1856369/000160183025000037/wk-form4_1741382181.xml","form_type":"4"}},{"id":1217652,"issuer":{"id":1008,"kind":"organization","name":"RECURSION PHARMACEUTICALS, INC.","symbol":"RXRX"},"owners":[{"id":40978,"kind":"person","name":"Gibson Christopher","position":1,"cik":"0001856369","reported_name":"Gibson Christopher","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Class A Common Stock","published_at":"2025-03-07T21:16:27.000Z","date":"2025-03-06","kind":"exercise","planned":true,"acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents the automatic conversion of Class B Common Stock into Class A Common Stock."},{"field":"kind","element":"transactionCoding","label":"F2","text":"This transaction is pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 27, 2023."}],"balance_after":1276024,"source":{"system":"sec-edgar","filing":"0001601830-25-000037","document":"wk-form4_1741382181.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1856369/000160183025000037/wk-form4_1741382181.xml","form_type":"4"}},{"id":1217651,"issuer":{"id":1008,"kind":"organization","name":"RECURSION PHARMACEUTICALS, INC.","symbol":"RXRX"},"owners":[{"id":40978,"kind":"person","name":"Gibson Christopher","position":1,"cik":"0001856369","reported_name":"Gibson Christopher","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Class A Common Stock","published_at":"2025-03-07T21:16:27.000Z","date":"2025-03-05","kind":"sale","planned":true,"acquired":false,"shares":20000,"price":6.58,"value":131600.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"This transaction is pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 27, 2023."}],"balance_after":1256024,"source":{"system":"sec-edgar","filing":"0001601830-25-000037","document":"wk-form4_1741382181.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1856369/000160183025000037/wk-form4_1741382181.xml","form_type":"4"}},{"id":1217650,"issuer":{"id":1008,"kind":"organization","name":"RECURSION PHARMACEUTICALS, INC.","symbol":"RXRX"},"owners":[{"id":40978,"kind":"person","name":"Gibson Christopher","position":1,"cik":"0001856369","reported_name":"Gibson Christopher","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Class A Common Stock","published_at":"2025-03-07T21:16:27.000Z","date":"2025-03-05","kind":"exercise","planned":true,"acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents the automatic conversion of Class B Common Stock into Class A Common Stock."},{"field":"kind","element":"transactionCoding","label":"F2","text":"This transaction is pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 27, 2023."}],"balance_after":1276024,"source":{"system":"sec-edgar","filing":"0001601830-25-000037","document":"wk-form4_1741382181.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1856369/000160183025000037/wk-form4_1741382181.xml","form_type":"4"}},{"id":1256053,"issuer":{"id":1008,"kind":"organization","name":"RECURSION PHARMACEUTICALS, INC.","symbol":"RXRX"},"owners":[{"id":40978,"kind":"person","name":"Gibson Christopher","position":1,"cik":"0001856369","reported_name":"Gibson Christopher","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Class A Common Stock","published_at":"2025-02-20T21:42:53.000Z","date":"2025-02-18","kind":"tax_withholding","planned":false,"acquired":false,"shares":17132,"price":10.64,"value":182284.48,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares that have been withheld by the Issuer to satisfy its tax withholding and remittance obligations in connection with the net settlement of restricted stock units."}],"balance_after":1256024,"source":{"system":"sec-edgar","filing":"0001601830-25-000020","document":"wk-form4_1740087766.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1856369/000160183025000020/wk-form4_1740087766.xml","form_type":"4"}},{"id":1278872,"issuer":{"id":1008,"kind":"organization","name":"RECURSION PHARMACEUTICALS, INC.","symbol":"RXRX"},"owners":[{"id":40978,"kind":"person","name":"Gibson Christopher","position":1,"cik":"0001856369","reported_name":"Gibson Christopher","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Class B Common Stock","published_at":"2025-02-07T21:14:35.000Z","date":"2025-02-06","kind":"exercise","planned":true,"acquired":false,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Each share of Class B Common Stock is convertible into one share of Class A Common Stock at the option of the holder and has no expiration date."},{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents the automatic conversion of Class B Common Stock into Class A Common Stock in connection with a bona-fide gift of shares by the Reporting Person"},{"field":"kind","element":"transactionCoding","label":"F2","text":"This transaction is pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 27, 2023."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Each share of Class B Common Stock is convertible into one share of Class A Common Stock at the option of the holder and has no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Each share of Class B Common Stock is convertible into one share of Class A Common Stock at the option of the holder and has no expiration date."}],"balance_after":5936700,"derivative":{"exercise_price":0,"underlying":"Class A Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001601830-25-000014","document":"wk-form4_1738962869.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1856369/000160183025000014/wk-form4_1738962869.xml","form_type":"4"}},{"id":1278871,"issuer":{"id":1008,"kind":"organization","name":"RECURSION PHARMACEUTICALS, INC.","symbol":"RXRX"},"owners":[{"id":40978,"kind":"person","name":"Gibson Christopher","position":1,"cik":"0001856369","reported_name":"Gibson Christopher","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Class B Common Stock","published_at":"2025-02-07T21:14:35.000Z","date":"2025-02-05","kind":"exercise","planned":true,"acquired":false,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Each share of Class B Common Stock is convertible into one share of Class A Common Stock at the option of the holder and has no expiration date."},{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents the automatic conversion of Class B Common Stock into Class A Common Stock in connection with a bona-fide gift of shares by the Reporting Person"},{"field":"kind","element":"transactionCoding","label":"F2","text":"This transaction is pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 27, 2023."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Each share of Class B Common Stock is convertible into one share of Class A Common Stock at the option of the holder and has no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Each share of Class B Common Stock is convertible into one share of Class A Common Stock at the option of the holder and has no expiration date."}],"balance_after":5956700,"derivative":{"exercise_price":0,"underlying":"Class A Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001601830-25-000014","document":"wk-form4_1738962869.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1856369/000160183025000014/wk-form4_1738962869.xml","form_type":"4"}},{"id":1278870,"issuer":{"id":1008,"kind":"organization","name":"RECURSION PHARMACEUTICALS, INC.","symbol":"RXRX"},"owners":[{"id":40978,"kind":"person","name":"Gibson Christopher","position":1,"cik":"0001856369","reported_name":"Gibson Christopher","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Class A Common Stock","published_at":"2025-02-07T21:14:35.000Z","date":"2025-02-06","kind":"sale","planned":true,"acquired":false,"shares":20000,"price":8.12,"value":162400.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"This transaction is pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 27, 2023."}],"balance_after":1273156,"source":{"system":"sec-edgar","filing":"0001601830-25-000014","document":"wk-form4_1738962869.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1856369/000160183025000014/wk-form4_1738962869.xml","form_type":"4"}},{"id":1278869,"issuer":{"id":1008,"kind":"organization","name":"RECURSION PHARMACEUTICALS, INC.","symbol":"RXRX"},"owners":[{"id":40978,"kind":"person","name":"Gibson Christopher","position":1,"cik":"0001856369","reported_name":"Gibson Christopher","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Class A Common Stock","published_at":"2025-02-07T21:14:35.000Z","date":"2025-02-06","kind":"exercise","planned":true,"acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents the automatic conversion of Class B Common Stock into Class A Common Stock in connection with a bona-fide gift of shares by the Reporting Person"},{"field":"kind","element":"transactionCoding","label":"F2","text":"This transaction is pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 27, 2023."}],"balance_after":1293156,"source":{"system":"sec-edgar","filing":"0001601830-25-000014","document":"wk-form4_1738962869.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1856369/000160183025000014/wk-form4_1738962869.xml","form_type":"4"}}],"next_cursor":"2025-02-07T21:14:35.000000Z,1278869"}